The PANIC Study in brief
The PANIC Study is a long-term lifestyle intervention and follow-up study involving a population-based cohort of 504 children aged 7–9 years at baseline (ClinicalTrials.gov: NCT01803776). Participants have been followed prospectively from mid-childhood through late childhood and adolescence into adulthood, with retrospective data extending back to fetal life. The study provides comprehensive multimodal, life-course data for investigating the development of health and chronic diseases and their underlying determinants and risk factors (PANIC metadata on Zenodo).
The baseline examinations were conducted in mid-childhood in 2007–2009, followed by assessments in late childhood in 2009–2011, adolescence in 2015–2017, and early adulthood in 2024–2026. The early-adulthood follow-up also included the PANIC Fat Biopsy Study, in which subcutaneous adipose tissue samples were collected for advanced molecular analyses. The next follow-up is planned for 2028–2030, when participants will be 27–29 years old.
Across all four study phases, comprehensive data have been collected on genetic and developmental factors, physical activity, diet, sleep, body composition, metabolic and cardiovascular health, physical fitness, cognitive and psychological functioning, neuromuscularand musculoskeletal health, oral health, pain, socioeconomic and environmental factors, and well-being. Prospective longitudinal data have been complemented by retrospective information on pregnancy, birth, early growth, and other early-life conditions.
At all four study phases, comprehensive assessments have included physical activity, sedentary behavior, diet, and sleep; growth, maturation, and body composition, including fat mass, lean mass, and bone mineral content and density measured by dual-energy X-ray absorptiometry (DXA); cardiorespiratory and neuromuscular fitness; cardiovascular health, including blood pressure; and clinical biomarkers such as measures of metabolic, hormonal, inflammatory, and oxidative stress. Insulin resistance has been estimated using the homeostatic model assessment for insulin resistance (HOMA-IR), calculated from fasting plasma glucose and serum insulin concentrations. Lipid metabolism has been characterized by measuring plasma total, LDL, and HDL cholesterol and triglyceride concentrations, as well as plasma fatty acid composition. These assessments have been complemented by extensive serum metabolomic profiling using liquid chromatography–mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy, as well as genome-wide genetic data. Additional assessments across the study have addressed oral health, including dental and orthodontic examinations and salivary analyses; psychological, social, and physical well-being; mental health; pain; and environmental determinants of health, including socioeconomic factors.
In adolescence and early adulthood, glucose tolerance and insulin responses to glucose have additionally been assessed using a 2-hour oral glucose tolerance test. Detailed assessments of cardiovascular health have included carotid artery ultrasonography to evaluate arterial structure and elasticity, measurements of arterial stiffness, autonomic cardiovascular regulation, and other measures of cardiovascular function. Cognitive function and brain structure and function have also been investigated through neuropsychological testing and complementary neurophysiological and brain imaging assessments, including those performed in the FitBrain Study, a PANIC substudy.
In early adulthood, magnetic resonance imaging (MRI) has been used to quantify abdominal subcutaneous and visceral adipose tissue and liver fat, while magnetic resonance spectroscopy (MRS) has provided additional quantitative assessment of liver fat. Retinal microcirculation has also been assessed to characterize retinal microvascular health. Moreover, the PANIC Fat Biopsy Study has collected subcutaneous adipose tissue samples for advanced molecular and multiomics analyses, including single-nucleus transcriptomics, chromatin accessibility profiling, spatial transcriptomics, and metabolomics.
The PANIC Study is conducted at the Institute of Biomedicine, School of Medicine, University of Eastern Finland (UEF), in collaboration with researchers from other units of UEF, Kuopio University Hospital, and several national and international universities, hospitals, and research institutes. The Principal Investigator is Timo A. Lakka, MD, PhD, Professor of Medical Physiology, Specialist in Internal Medicine, and Adjunct Professor of Public Health (Connect; PubMed).
Research Aims:
The PANIC Study aims to investigate:
- Risk factors and pathophysiological mechanisms underlying the development of chronic diseases and conditions—including obesity, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), atherosclerotic cardiovascular disease, cognitive disorders, osteoporosis, mental health disorders, oral diseases, and chronic pain—from fetal life to adulthood.
- The long-term effects of physical activity, diet, and other lifestyle factors on these chronic diseases and conditions and their modifiable risk factors from childhood to adulthood.
- How genetic, developmental, and environmental factors modify the long-term effects of physical activity, diet, and other lifestyle factors on these diseases and conditions and their modifiable risk factors across the life course.
- Factors influencing health care utilization and costs, and the cost-effectiveness of lifestyle interventions and other strategies for preventing chronic diseases and conditions.
